Introduction to Cervical Cancer
Cervical Cancer remains one of the most preventable yet deadly diseases affecting women globally. Every two minutes, a woman somewhere in the world dies from cervical cancer. This tragic reality is even more pronounced in Africa, which accounts for 23% of global deaths, despite representing just over 17% of the world’s female population. The disparity in mortality rates is alarming and reflects systemic barriers that, if addressed, could save countless lives.
10 years ago, this form of cancer ranked as the third most common cancer among women worldwide. However, in 42 low-resource countries, it was the most common cancer in women. The knowledge that persistent infection with carcinogenic human papillomavirus (HPV) types is the main cause in triggering the development of cervical cancer has opened new pathways for primary and secondary prevention.The implementation of both methods of prevention can make cervical cancer occurrence and death largely avoidable.
Consistent evidence indicates that the licensed bivalent and quadrivalent HPV vaccines containing HPV16 and HPV18 antigens protect with high efficacy against infection and precancerous cervical lesions associated with these types when individuals are not yet exposed. Both types jointly cause 70–75% of all cervical cancers and 40–60% of its precursors.
The Preventability of Cervical Cancer
It is well-established that this cancer is almost entirely preventable through vaccination against the human papillomavirus (HPV) and routine screening. HPV is responsible for the vast majority of cervical cancer cases, and the availability of vaccines that protect against the most cancer-causing strains of the virus has made it possible to prevent the disease before it starts. Additionally, regular screening through Pap smears and HPV tests can detect precancerous changes in the cervix, allowing for early intervention before cancer develops.
Despite the availability of these preventive measures, this cancer remains a leading cause of cancer deaths among women, particularly in low- and middle-income countries. In Africa, where healthcare infrastructure is often under-resourced, the challenges are particularly acute.
The Path Forward
Addressing the cervical cancer crisis in Africa requires a multi-faceted approach that tackles these barriers head-on.
- Scaling Up Vaccination Programs: There is a critical need to expand access to HPV vaccines across Africa. This will require not only reducing the cost of vaccines but also investing in the infrastructure needed to deliver them, particularly in rural and underserved areas. Global health organizations, governments, and private sector partners must work together to ensure that every girl in Africa has the opportunity to be vaccinated against HPV.
- Expanding Screening and Treatment Services: Screening programs need to be scaled up to reach more women, especially in rural areas. This includes training healthcare workers, providing the necessary equipment, and ensuring that women who are screened have access to appropriate follow-up care. Mobile clinics and community health workers can play a crucial role in reaching women in remote areas.
- Raising Awareness and Education: Education campaigns are essential to raise awareness about the importance of cervical cancer prevention. These campaigns should be culturally sensitive and designed to reach women where they are, whether through schools, community groups, or media channels.
- Strengthening Healthcare Systems: Ultimately, long-term success in preventing cervical cancer will depend on strengthening healthcare systems across Africa. This includes investing in healthcare infrastructure, training healthcare workers, and ensuring that healthcare services are accessible to all women, regardless of where they live.
Below is the four tiers of HDI are the following: very high (HDI ≥0·8), high (HDI <0·8 to ≥0·7), medium (HDI <0·7 to ≥0·55), and low (HDI <0·55). HDI=Human Development Index.
Conclusion
The fight against cervical cancer in africa is a moral imperative. Every two minutes, a woman’s life is cut short by a disease that we have the tools to prevent. By addressing the barriers of cost and access, and by making a concerted effort to expand vaccination, screening, and education, we can dramatically reduce the number of women who die from this preventable disease. The time to act is now.
Join Tishha
